Get the Stockscreener App
41.96
4.04%
1.63
After Hours:
41.96
Neurogene Inc stock is traded at $41.96, with a volume of 150.95K.
It is up +4.04% in the last 24 hours and up +12.13% over the past month.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.
See More
Previous Close:
$40.33
Open:
$40.23
24h Volume:
150.95K
Relative Volume:
1.17
Market Cap:
$524.03M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.59%
1M Performance:
+12.13%
6M Performance:
-17.56%
1Y Performance:
+0.00%
1-Day Range:
$39.25
$43.05
1-Week Range:
$38.56
$44.75
52-Week Range:
$15.19
$53.00
Neurogene Inc Stock (NGNE) Company Profile
Name
Neurogene Inc
Sector
Industry
Phone
(877) 237-5020
Address
535 W 24TH STREET, NEW YORK
Neurogene Inc Stock (NGNE) Latest News
Neurogene Inc. (NASDAQ:NGNE) Stake Raised by Driehaus Capital Management LLC - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Rhumbline Advisers Invests $491,000 in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Neurogene (NASDAQ:NGNE) Trading Up 8.2% - MarketBeat
Closing Bell Recap: Neurocrine Biosciences, Inc. (NBIX) Ends at 116.49, Reflecting a -1.07 Downturn - The Dwinnex
Nebius to invest more than USD 1 billion to build AI infrastructure in Europe - sharewise
Renaissance Technologies LLC Raises Holdings in N-able, Inc. (NYSE:NABL) - Defense World
XTX Topco Ltd Sells 4,464 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Rhumbline Advisers Has $721,000 Stock Holdings in NETGEAR, Inc. (NASDAQ:NTGR) - Defense World
Raffles Associates LP Has $3.36 Million Holdings in NB Bancorp, Inc. (NASDAQ:NBBK) - Defense World
BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING - WV News
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by American Century Companies Inc. - Defense World
Integral Health Asset Management LLC Buys New Shares in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
70,000 Shares in Neurogene Inc. (NASDAQ:NGNE) Purchased by Integral Health Asset Management LLC - Defense World
NTAP (Netapp Inc) may reap gains as insiders became active recently - Knox Daily
1832 Asset Management L.P. Increases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - Defense World
Ensign Peak Advisors Inc Increases Holdings in NetApp, Inc. (NASDAQ:NTAP) - Defense World
Avoro Capital Advisors LLC Makes New Investment in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Hollencrest Capital Management Buys New Stake in NetApp, Inc. (NASDAQ:NTAP) - Defense World
NetApp, Inc. (NASDAQ:NTAP) Shares Sold by Amalgamated Bank - Defense World
Bank of New York Mellon Corp Purchases New Stake in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Bank of New York Mellon Corp Takes $1.11 Million Position in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
(NBIX) Trading Advice - Stock Traders Daily
Promethos Capital LLC Invests $107,000 in NetApp, Inc. (NASDAQ:NTAP) - Defense World
10,295 Shares in Neuberger Berman Next Generation Connectivity Fund Inc. (NYSE:NBXG) Purchased by Carolinas Wealth Consulting LLC - Defense World
2,056 Shares in NetApp, Inc. (NASDAQ:NTAP) Purchased by Waterloo Capital L.P. - Defense World
Quest Partners LLC Invests $55,000 in Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene (NASDAQ:NGNE) Stock Price Up 4.8% - MarketBeat
Neurogene (NASDAQ:NGNE) Shares Down 2.7% - MarketBeat
Rett Syndrome Market Expected to Experience Major Growth - openPR
Neurogene Inc. (NASDAQ:NGNE) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Buy” from Analysts - Defense World
Investors in cash trouble should check out Neurogene Inc (NGNE) - SETE News
Neurogene's (NASDAQ:NGNE) Earnings Might Be Weaker Than You Think - Yahoo Finance
Q3 2024 Earnings Forecast for Neurogene Inc. (NASDAQ:NGNE) Issued By HC Wainwright - Defense World
Q3 2024 Earnings Forecast for Neurogene Inc. (NASDAQ:NGNE) Issued By HC Wainwright - MarketBeat
Neurogene stock holds Outperform with steady target on RMAT designation - Investing.com
Neurogene stock holds Outperform with steady target on RMAT designation By Investing.com - Investing.com Canada
Neurogene stock holds Outperform with steady target on RMAT designation By Investing.com - Investing.com UK
HC Wainwright Lowers Neurogene (NASDAQ:NGNE) Price Target to $49.00 - MarketBeat
Neurogene’s NGN-401 Shows Promise for Rett Syndrome - TipRanks
Neurogene’s NGN-401 Wins Key FDA Designation - TipRanks
HC Wainwright Cuts Neurogene (NASDAQ:NGNE) Price Target to $49.00 - Defense World
Vanguard Group Inc. Increases Position in Neurogene Inc. (NASDAQ:NGNE) - MarketBeat
Vanguard Group Inc. Buys 457,062 Shares of Neurogene Inc. (NASDAQ:NGNE) - Defense World
Neurogene: Q2 Earnings Snapshot - San Francisco Chronicle
Neurogene Reports Second Quarter 2024 Financial Results and Highlights Recent Updates - businesswire.com
Neurogene Reports Second Quarter 2024 Financial Results and Highlights Recent Updates - Yahoo Finance
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
Neurogene Inc. (NASDAQ:NGNE) Receives Consensus Rating of “Buy” from Brokerages - Defense World
Neurogene Announces RMAT Designation for NGN-401 Investigational Gene Therapy for Rett Syndrome - Lelezard
Neurogene Inc Stock (NGNE) Financials Data
There is no financial data for Neurogene Inc (NGNE). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):